PPARA and liver cancer: We hypothesized that PPARɣ agonists exert their renoprotective effect by inhibiting the expression of glomerular HPSE since HPSE is essential for the development of proteinuria, TZDs reduce proteinuria, and PPARɣ regulates HPSE expression in liver cancer cells.